1060 million people with ‘other’ musculoskeletal disorders by 2050

Publicly released:
Australia; New Zealand; SA; TAS
Getty Images
Getty Images

A category of musculoskeletal disorders of our joints, muscles, bones, ligaments, tendons and spine are on the rise and a new forecast is as many as 1060 million people – up from 464 million – will be living with related disabilities by 2050, placing even greater pressure on stretched healthcare systems. Published in the latest edition of Lancet Rheumatology, the Global Burden of Disease research was funded by the Bill and Melinda Gates Foundation and used population, health and insurance claims data across 204 countries and territories to measure the prevalence, years of life lived with disability and population data to identify the 2050 projection.

Media release

From: Flinders University

A category of musculoskeletal disorders of our joints, muscles, bones, ligaments, tendons and spine are on the rise and a new forecast is as many as 1060 million people – up from 464 million – will be living with related disabilities by 2050, placing even greater pressure on stretched healthcare systems.

Published in the latest edition of Lancet Rheumatology, the Global Burden of Disease research was funded by the Bill and Melinda Gates Foundation and used population, health and insurance claims data across 204 countries and territories to measure the prevalence, years of life lived with disability and population data to identify the 2050 projection.

“We highlight there is a substantial burden of what are categorised as ‘other’ musculoskeletal disorders that would otherwise go unrecognised,” says joint first author Manasi Murthy Mittinty, Flinders University College of Medicine and Public Health Senior Lecturer and Harvard Medical School Advanced Global Clinical Scholar Research Fellow.

“The research team has identified that musculoskeletal disorders of the types studied in this research, which excludes osteoarthritis, rheumatoid arthritis, gout, low back pain and neck pain, are a large and growing source of disability in the world that requires public policy consideration,” she says.

“We based our forecast on population projections and ageing demographics, indicating that not only are the number of people worldwide living with other musculoskeletal conditions such as systemic lupus erythematosus and spondylopathies increasing but so will be their healthcare needs in 2050 and beyond.”

The research team identified:

  • ‘Other’ musculoskeletal disorders are a heterogeneous group of musculoskeletal conditions not captured elsewhere in disease-specific categories and are often overlooked in policy for musculoskeletal health;
  • ‘Other’ musculoskeletal disorders in 2020 ranked as the sixth-largest cause of years lived with disability (YLDs), 19th-largest cause of DALYs (Disability Adjusted Life years (DALYs);
  • Large YLD burden, despite all uncertainty, suggests high demand for therapeutic and rehabilitative services and is supported by insurance claims data indicating large number of health service visits.

Dr Mittinty says the research found musculoskeletal disorders globally are reported higher in females, increase overall with age and peak at 60-69 years.

“We have forecast the 494 million cases in 2020 is projected to grow substantially to reach 1060 million people living with other musculoskeletal disabilities by 2050.

“A factor which may add to the projection of course is the emergence of post-COVID-19 implications where a growing cohort of related conditions characterised by musculoskeletal symptoms and loss of mobility are recognised, adding further pressure on health systems and communities.”

Co-lead author with Dr Mittinty is Dr Tiffany Gill, from the University of Adelaide Medical School.

Global, regional and national burden of other musculoskeletal disorders, 1990-2020, and projections to 2050: a systematic analysis of the Global Burden of Disease Study 2021 published in Lancet Rheumatology, Volume 5, Issue 11, November 2023

Attachments

Note: Not all attachments are visible to the general public. Research URLs will go live after the embargo ends.

Research Flinders University, Web page Research Publication
Journal/
conference:
The Lancet Rheumatology
Research:Paper
Organisation/s: Flinders University, University of Tasmania
Funder: Bill & Melinda Gates Foundation. L M Bearne acknowledges support from St George's, University of London (London, UK). M Cross acknowledges support from the Global Alliance for Musculoskeletal Health (Sydney, NSW, Australia) and the Bone and Joint Decade Foundation (Lund, Sweden). M J Khan acknowledges support from The Hong Kong Polytechnic University (Hong Kong Special Administrative Region, China). K Krishan acknowledges non-financial support from the UGC Centre of Advanced Study, CAS II, Department of Anthropology, Panjab University (Chandigarh, India), outside the submitted work. I Landires acknowledges support as a member of the Sistema Nacional de Investigación, which is supported by the Secretaria Nacional de Ciencia y Tecnologia (Panama City, Panama). L Monasta acknowledges support from the Italian Ministry of Health (Ricerca Corrente 34/2017; payments made to the Institute for Maternal and Child Health IRCCS Burlo Garofolo, Trieste, Italy). P Pedersini acknowledges support from the Italian Ministry of Health (Ricerca Corrente 2023). I Qattea acknowledges support from the Cleveland Clinic Foundation (Cleveland, OH, USA). E M M Redwan acknowledges support from King Abdulaziz University (Deanship of Scientific Research; Jeddah, Saudi Arabia), King Abdulaziz City for Science and Technology (KACSAT; Riyadh, Saudi Arabia), Science and Technology Development Fund (STDF; Cairo, Egypt), the US–Egypt Science and Technology Joint Fund (Cairo, Egypt), and the Academy of Scientific Research & Technology (ASRT; Cairo, Egypt). D C Ribeiro acknowledges funding support from The Sir Charles Hercus Health Research Fellowship of the Health Research Council of New Zealand (grant number 18/111). S Sharma acknowledges support from the John J Bonica Postdoctoral Fellowship from the International Association for the Study of Pain. A Singh acknowledges support from the International Graduate Research Scholarship, University of Tasmania (Hobart, TAS, Australia). M Tabish acknowledges support from Shaqra University (Shaqra, Saudi Arabia). Editorial note: The Lancet Group takes a neutral position with respect to territorial claims in published text, maps, and institutional affiliations.
Media Contact/s
Contact details are only visible to registered journalists.